FindTrial
Sign In

Clinical pharmacist intervention in promoting urinary tract infection(UTI) prevention and rational antibiotic use in pregnant women

A prospective interventional study on the role of clinical pharmacist led strategies in preventing UTI and promoting rational antibiotic use among pregnant women - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102276
Enrollment
188
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Clinical pharmacist role in promoting urinary tract infection (UTI)prevention and rationale antibiotic use in pregnant women: Clinical pharmacist role in promoting urinary tract infecti

Sponsors

YAnitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pregnant women attending antenatal clinics during the study period. 2.Women in any trimester of pregnancy. 3.Those who provide written informed consent to participate. 4.Women capable of responding to interview questions or completing questionnaires

Exclusion criteria

Exclusion criteria: 1.Non-pregnant women. 2.Pregnant women with severe systemic illnesses 3.Participants on long-term antibiotic prophylaxis for other conditions. 4.Those who decline consent or are unable to communicate effectively

Design outcomes

Primary

MeasureTime frame
To evaluate the role of clinical pharmacist in the prevention,early detection and rationale antibiotic managemnt of (UTI) among pregnant womensTimepoint: Baseline,4 weeks, 8 weeks,12 weeks, 16 weeks, 20 weeks, 24 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDrI Murali

Balaji college of pharmacy

muraliiguduru14@gmail.com6300358140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026